Please assess the completion status of the following clinical trial:

Trial Title: Study of Milnacipran for the Treatment of Fibromyalgia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria~Exclusion Criteria:~* Psychiatric illness~* Depression~* Suicidal risk~* Substance abuse~* Pulmonary dysfunction~* Renal impairment~* Active cardiac disease~* Liver disease~* Autoimmune disease~* Cancer~* Sleep apnea~* Inflammatory bowel disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).